Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |